CLINICAL_TRIALS
trial_result
· 2017-06-07
Clinical Trial Update: A Safety and Efficacy Study of Refresh Optive® Gel Drops in Patients With Dry Eye Disease [Phase 3]
Summary
Phase 3 trial update evaluating safety and efficacy of Refresh Optive Gel Drops for dry eye disease has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Allergan | Conditions: Dry Eye Syndromes | Phase 3 | Status: COMPLETED | Results posted: 2017-06-07